リソソーム酸リパーゼ欠乏症（LAAL）治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C3509
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、120ページ
• 納品方法：Eメール
• 産業分類：Medical Care

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、リソソーム酸リパーゼ欠乏症（LAAL）治療の世界市場について調べ、まとめました。種類別セグメントは、酵素補充療法、腎臓移植、幹細胞移植等、用途別セグメントは、等に区分しました。リソソーム酸リパーゼ欠乏症（LAAL）治療の世界市場概観、企業動向、企業別リソソーム酸リパーゼ欠乏症（LAAL）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・リソソーム酸リパーゼ欠乏症（LAAL）治療の市場概観
・リソソーム酸リパーゼ欠乏症（LAAL）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・リソソーム酸リパーゼ欠乏症（LAAL）治療の企業別販売動向、市場シェア、市場集中度、競争動向
・リソソーム酸リパーゼ欠乏症（LAAL）治療の世界市場規模
・リソソーム酸リパーゼ欠乏症（LAAL）治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・リソソーム酸リパーゼ欠乏症（LAAL）治療のアメリカ市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療のカナダ市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療のメキシコ市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・リソソーム酸リパーゼ欠乏症（LAAL）治療のドイツ市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療のイギリス市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療のロシア市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・リソソーム酸リパーゼ欠乏症（LAAL）治療の日本市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療の中国市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療の韓国市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療のインド市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療の東南アジア市場規模推移
・リソソーム酸リパーゼ欠乏症（LAAL）治療の南米市場分析（ブラジル、アルゼンチン等）
・リソソーム酸リパーゼ欠乏症（LAAL）治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・リソソーム酸リパーゼ欠乏症（LAAL）治療の種類別分析/販売量、売上、市場シェア（酵素補充療法、腎臓移植、幹細胞移植）
・リソソーム酸リパーゼ欠乏症（LAAL）治療の用途別分析/市場規模（）
・リソソーム酸リパーゼ欠乏症（LAAL）治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・リソソーム酸リパーゼ欠乏症（LAAL）治療の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lysosomal Acid Lipase Deficiency (LAAL) Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Lysosomal Acid Lipase Deficiency (LAAL) Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lysosomal Acid Lipase Deficiency (LAAL) Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
AstraZeneca plc
Merck & Co., Inc
Pfizer, Inc.
Alexion Pharmaceutical Inc
Lonza Group Ltd.
hermo Fisher Scientific
Teva Pharmaceutical Industries Ltd.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Enzyme Replacement Therapy
Kidney Transplantation
Stem Cell Transplantation

Market Segment by Applications, can be divided into
Wolman Disease
Cholesterol Ester Storage Disease (CESD)

レポート目次

Table of Contents

1 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Overview
1.1 Product Overview and Scope of Lysosomal Acid Lipase Deficiency (LAAL) Treatment
1.2 Classification of Lysosomal Acid Lipase Deficiency (LAAL) Treatment by Types
1.2.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Types in 2018
1.2.3 Enzyme Replacement Therapy
1.2.4 Kidney Transplantation
1.2.5 Stem Cell Transplantation
1.3 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market by Application
1.3.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Wolman Disease
1.3.3 Cholesterol Ester Storage Disease (CESD)
1.4 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market by Regions
1.4.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Lysosomal Acid Lipase Deficiency (LAAL) Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Lysosomal Acid Lipase Deficiency (LAAL) Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lysosomal Acid Lipase Deficiency (LAAL) Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Lysosomal Acid Lipase Deficiency (LAAL) Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lysosomal Acid Lipase Deficiency (LAAL) Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Lysosomal Acid Lipase Deficiency (LAAL) Treatment (2014-2024)
2 Manufacturers Profiles
2.1 AstraZeneca plc
2.1.1 Business Overview
2.1.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca plc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck & Co., Inc
2.2.1 Business Overview
2.2.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck & Co., Inc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer, Inc.
2.3.1 Business Overview
2.3.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer, Inc. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Alexion Pharmaceutical Inc
2.4.1 Business Overview
2.4.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Alexion Pharmaceutical Inc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Lonza Group Ltd.
2.5.1 Business Overview
2.5.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Lonza Group Ltd. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 hermo Fisher Scientific
2.6.1 Business Overview
2.6.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 hermo Fisher Scientific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Teva Pharmaceutical Industries Ltd.
2.7.1 Business Overview
2.7.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Pharmaceutical Industries Ltd. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Competition, by Players
3.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Players Market Share
3.2.2 Top 10 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Players Market Share
3.3 Market Competition Trend
4 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size by Regions
4.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Market Share by Regions
4.2 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
5 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries
5.1 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries (2014-2019)
5.2 USA Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
6 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries
6.1 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries (2014-2019)
6.2 Germany Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
6.4 France Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries
7.1 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries (2014-2019)
7.2 China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
7.5 India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
8 South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries
8.1 South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries (2014-2019)
8.2 Brazil Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Lysosomal Acid Lipase Deficiency (LAAL) Treatment by Countries
9.1 Middle East and Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
10 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Segment by Type
10.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast by Type (2019-2024)
10.3 Enzyme Replacement Therapy Revenue Growth Rate (2014-2024)
10.4 Kidney Transplantation Revenue Growth Rate (2014-2024)
10.5 Stem Cell Transplantation Revenue Growth Rate (2014-2024)
11 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Segment by Application
11.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Application (2014-2019)
11.2 Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast by Application (2019-2024)
11.3 Wolman Disease Revenue Growth (2014-2019)
11.4 Cholesterol Ester Storage Disease (CESD) Revenue Growth (2014-2019)
12 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Forecast (2019-2024)
12.1 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size Forecast (2019-2024)
12.2 Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Forecast by Regions (2019-2024)
12.3 North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Forecast (2019-2024)
12.6 South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Picture
Table Product Specifications of Lysosomal Acid Lipase Deficiency (LAAL) Treatment
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Types in 2018
Figure Enzyme Replacement Therapy Picture
Figure Kidney Transplantation Picture
Figure Stem Cell Transplantation Picture
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) by Application (2014-2024)
Figure Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Applications in 2018
Figure Wolman Disease Picture
Figure Cholesterol Ester Storage Disease (CESD) Picture
Table Global Market Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table AstraZeneca plc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
Table AstraZeneca plc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
Table Merck & Co., Inc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer, Inc. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
Table Pfizer, Inc. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Alexion Pharmaceutical Inc Basic Information, Manufacturing Base and Competitors
Table Alexion Pharmaceutical Inc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
Table Alexion Pharmaceutical Inc Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Lonza Group Ltd. Basic Information, Manufacturing Base and Competitors
Table Lonza Group Ltd. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
Table Lonza Group Ltd. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table hermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table hermo Fisher Scientific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
Table hermo Fisher Scientific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Ltd. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Type and Applications
Table Teva Pharmaceutical Industries Ltd. Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Share by Players (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Share by Players in 2017
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share in 2018
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Regions in 2018
Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Table North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries (2014-2019)
Table North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries in 2018
Figure USA Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Table Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries in 2018
Figure Germany Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure UK Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure France Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries in 2018
Figure China Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure India Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Table South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Countries (2014-2019)
Table South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries in 2018
Figure Brazil Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue and Growth Rate (2014-2019)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Share by Type (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Share by Type (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Share by Type in 2019
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Forecast by Type (2019-2024)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share Forecast by Type (2019-2024)
Figure Global Enzyme Replacement Therapy Revenue Growth Rate (2014-2019)
Figure Global Kidney Transplantation Revenue Growth Rate (2014-2019)
Figure Global Stem Cell Transplantation Revenue Growth Rate (2014-2019)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue by Application (2014-2019)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Share by Application (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Share by Application (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Share by Application in 2019
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Forecast by Application (2019-2024)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Share Forecast by Application (2019-2024)
Figure Global Wolman Disease Revenue Growth Rate (2014-2019)
Figure Global Cholesterol Ester Storage Disease (CESD) Revenue Growth Rate (2014-2019)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Forecast (2019-2024)
Figure Europe Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Forecast (2019-2024)
Figure South America Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Lysosomal Acid Lipase Deficiency (LAAL) Treatment Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介

世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測

Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7488 2019年6月14日 97Pages
当資料は、リソソーム酸リパーゼ欠乏症（LAAL）の治療のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、腎臓移植、幹細胞移植）、用途別（ウォルマン病、コレステロールエステル蓄積症（CESD））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...

ビタミンD欠乏症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Vitamin D Deficiency Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6250 2019年7月 123Pages
本調査レポートは、ビタミンD欠乏症治療の世界市場について調べ、まとめました。種類別セグメントは、ビタミンD2、ビタミンD3等、用途別セグメントは、等に区分しました。ビタミンD欠乏症治療の世界市場概観、企業動向、企業別ビタミンD欠乏症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主...

ムコ多糖症（MPS）治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Mucopolysaccharidosis (MPS) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C3880 2019年8月 117Pages
本調査レポートは、ムコ多糖症（MPS）治療の世界市場について調べ、まとめました。種類別セグメントは、幹細胞療法、酵素補充療法等、用途別セグメントは、病院、診療所、その他等に区分しました。ムコ多糖症（MPS）治療の世界市場概観、企業動向、企業別ムコ多糖症（MPS）治療シェア、市場規模推移、市場規模予測...

神経内分泌腫瘍（NET）治療の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Neuroendocrine Tumors (NETs) Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C3995 2019年8月 119Pages
本調査レポートは、神経内分泌腫瘍（NET）治療の世界市場について調べ、まとめました。種類別セグメントは、ソマトスタチンアナログ（SSA）、標的療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。神経内分泌腫瘍（NET）治療の世界市場概観、企業動向、企業別神経内分泌腫瘍（NET）...

世界のチロシンヒドロキシラーゼ欠乏症の治療市場：市場規模・現状・予測

Global Tyrosine Hydroxylase Deficiency Treatment Market Size, Status and Forecast 2019-2025
QYR9N8152 2019年6月14日 92Pages
当資料は、チロシンヒドロキシラーゼ欠乏症の治療のグローバル市場について調査・分析したレポートで、種類別（薬、言語療法、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...

酸性スフィンゴミエリナーゼ欠乏性薬市場：世界及び中国の市場分析・予測（～2024年）

Acid Sphingomyelinase Deficiency Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9J10168 2019年7月 139Pages
世界及び中国における酸性スフィンゴミエリナーゼ欠乏性薬市場について調査・分析したレポートで、酸性スフィンゴミエリナーゼ欠乏性薬の世界市場動向、市場規模、主要企業情報などが含まれています。酸性スフィンゴミエリナーゼ欠乏性薬の種類別・用途別に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国など...

リパーゼ市場：世界及び中国市場分析・予測（～2024年）

Lipase Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9J07433 2019年7月 145Pages
世界及び中国におけるリパーゼ市場について調査・分析したレポートで、リパーゼの世界市場動向、市場規模、主要企業情報などが含まれています。リパーゼの種類別には、微生物リパーゼ、動物リパーゼに分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。
・リパーゼ...

世界のリソソーム蓄積症治療薬市場：市場規模・現状・予測

Global Lysosomal Storage Diseases Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7490 2019年6月14日 97Pages
当資料は、リソソーム蓄積症治療薬のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、幹細胞療法、基板削減療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...

世界のチロシンヒドロキシラーゼ欠乏薬市場：市場規模・現状・予測

Global Tyrosine Hydroxylase Deficiency Drugs Market Size, Status and Forecast 2019-2025
QYR9N8151 2019年6月14日 99Pages
当資料は、チロシンヒドロキシラーゼ欠乏薬のグローバル市場について調査・分析したレポートで、種類別（トリヘキシフェニジル、アマンタジン、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界のリソソーム蓄積症（LSD）市場：市場規模・現状・予測

Global Lysosomal Storage Disease (LSD) Market Size, Status and Forecast 2019-2025
QYR9N7489 2019年6月14日 94Pages
当資料は、リソソーム蓄積症（LSD）のグローバル市場について調査・分析したレポートで、種類別（脂質代謝異常、糖タンパク質代謝異常）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測 Lysosomal acid lipase deficiency (LAAL) is an autosomal recessive genetic disorder caused due to mutation in LIPE (Lipase E) gene which encodes the lysosomal acid lipase proteins on chromosome 10q23.31.In terms of region, due to high prevalence of lysosomal acid lipase deficiency disease, Europe and…
ビタミンD欠乏症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Vitamin D Deficiency Treatment market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also…
酸性スフィンゴミエリナーゼ欠乏性薬市場：世界及び中国の市場分析・予測（～2024年） Acid Sphingomyelinase Deficiency Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Acid Sphingomyelinase Deficiency Drug industry with a focus on the Chinese market. The report provides key statistics on the market status o…
世界のチロシンヒドロキシラーゼ欠乏症の治療市場：市場規模・現状・予測 The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
リパーゼ市場：世界及び中国市場分析・予測（～2024年） Lipase Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Lipase industry with a focus on the Chinese market. The report provides key statistics on the market status of the Lipase manufacturers and is a valuable source of guidanc…